Radiant Biotherapeutics, Inc. is a biotechnology company focused on developing drug pipelines and therapeutic platforms primarily addressing neoplasms and other disease domains. The company operates in Canada with a growing team of professionals engaged in advanced biotherapeutic research.
Subscribe to see Radiant Biotherapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Radiant Biotherapeutics Inc. is a biotechnology company headquartered in Canada. It has raised at least $42.3M across the 2 funding rounds on record. Its most recent funding round raised $34.3M in August 2024. Xcout tracks 3 named people at Radiant Biotherapeutics Inc., including Arthur Fratamico (Chief Executive Officer of the Issuer).
As of 16 November 2026. Source: Xcout Intel.
At least $42.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $34.3M | — | |
| Series A | $8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Radiant Biotherapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Radiance Biopharma, Inc. is a biotechnology company incorporated under Delaware law with a presence in Boston, Massachusetts. The company focuses on drug pipelines and therapeutic areas addressing neoplasms and other disease domains.
Radar Therapeutics, Inc. is a United States-based holding and biotechnology company located in California that focuses on drug pipelines and therapeutic innovations.
Resonant Therapeutics, Inc. is a biotechnology company headquartered in Houston, Texas, focused on cancer therapeutic discovery based on unique insights.
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Orion Biotechnology Canada Ltd. is a drug discovery and development company headquartered in Ottawa, Canada. Founded in 2017, the firm focuses on researching and developing innovative therapeutics targeting complex diseases. Its scientific pipeline utilizes proprietary drug design platforms to create novel targeted treatments.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Radiant Biotherapeutics Inc.? Suggest a correction · Work at Radiant Biotherapeutics Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.